TUBA1C expression promotes proliferation by regulating the cell cycle and indicates poor prognosis in glioma

This study demonstrated that high TUBA1C expression correlated with poor outcomes in glioma patients and that knocking down TUBA1C suppressed glioma cell proliferation via cell cycle arrest. In addition, TUBA1C might be a therapeutic biomarker for gliomas.PMID:34517210 | DOI:10.1016/j.bbrc.2021.08.079

Source: Biochemical and Biophysical Research communications - September 13, 2021 Category: Biochemistry Authors: Shikai Gui Peng Chen Yu Liu Qiaorong Chen Tianxiang Cheng Shulong Lv Tong Zhou Zhen Song Juexian Xiao Wei He Shengtao Yuan Zujue Cheng Source Type: research